Millennium Management’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.8M Buy
+300,000
New +$11.6M ﹤0.01% 2134
2025
Q2
– Sell
-7,000
Closed -$232K – 6062
2025
Q1
$232K Buy
+7,000
New +$251K ﹤0.01% 5230
2023
Q1
– Sell
-14,000
Closed -$771K – 6569
2022
Q4
$771K Buy
+14,000
New +$770K ﹤0.01% 4404

Other funds holding HRMY

Millennium Management's HRMY Position: Q3 2026 in Review

Millennium Management reduced its Harmony Biosciences (HRMY) stake by 93% in Q3 2026, selling an estimated $11.5M and leaving 20,952 shares worth $823K. The position accounts for ﹤0.01% of the portfolio, ranked #4628.

Millennium Management first reported a position in HRMY in Q3 2020 and has held it in 24 quarters since. The position peaked at $26.7M in Q1 2026. 358 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • Millennium Management held 20,952 shares of Harmony Biosciences worth $823K as of Q3 2026.
  • Millennium Management sold 298,860 Harmony Biosciences shares in Q3 2026, an estimated $11.5M.
  • Harmony Biosciences made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #4628 holding.
  • Millennium Management first reported a position in Harmony Biosciences in Q3 2020 and has held it in 24 quarters since.
  • Millennium Management's Harmony Biosciences position peaked at $26.7M in Q1 2026.
  • 358 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.